Literature DB >> 35722878

Variation in Mean Arterial Pressure Increases Falls Risk in Elderly Physically Frail and Prefrail Individuals Treated With Antihypertensive Medication.

Sultana Monira Hussain1,2, Michael E Ernst3, Anna L Barker1, Karen L Margolis4, Christopher M Reid1, Johannes T Neumann1,5, Andrew M Tonkin1, Thao Le Thi Phuong1, Lawrence J Beilin6, Thao Pham1, Enayet K Chowdhury1, Flavia M Cicuttini1, Julia F M Gilmartin-Thomas1,7,8, Prudence R Carr1, John J McNeil1.   

Abstract

BACKGROUND: Impaired cerebral blood flow has been associated with an increased risk of falls. Mean arterial pressure (MAP) and variability in MAP have been reported to affect cerebral blood flow but their relationships to the risk of falls have not previously been reported.
METHODS: Utilising data from the Aspirin in Reducing Events in the Elderly trial participants, we estimated MAP and variability in MAP, defined as within-individual SD of MAP from baseline and first 2 annual visits. The relationship with MAP was studied in 16 703 participants amongst whom 1539 falls were recorded over 7.3 years. Variability in MAP was studied in 14 818 of these participants who experienced 974 falls over 4.1 years. Falls were confined to those involving hospital presentation. Cox regression was used to calculate hazard ratio and 95% CI for associations with falls.
RESULTS: Long-term variability in MAP was not associated with falls except amongst frail or prefrail participants using antihypertensive medications. Within this group each 5 mm Hg increase in long-term variability in MAP increased the risk of falls by 16% (hazard ratio, 1.16 [95% CI, 1.02-1.33]). Amongst the antihypertensive drugs studied, beta-blocker monotherapy (hazard ratio, 1.93 [95% CI, 1.17-3.18]) was associated with an increased risk of falls compared with calcium channel blockers.
CONCLUSIONS: Higher levels of long-term variability in MAP increase the risk of serious falls in older frail and prefrail individuals taking antihypertensive medications. The observation that the relationship was limited to frail and prefrail individuals might explain some of the variability of previous studies linking blood pressure indices and falls.

Entities:  

Keywords:  arterial pressure; aspirin; blood pressure; cardiovascular diseases; frailty

Mesh:

Substances:

Year:  2022        PMID: 35722878      PMCID: PMC9378722          DOI: 10.1161/HYPERTENSIONAHA.122.19356

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   9.897


  47 in total

1.  A randomised controlled trial of low-dose aspirin for the prevention of fractures in healthy older people: protocol for the ASPREE-Fracture substudy.

Authors:  Anna L Barker; John J McNeil; Ego Seeman; Stephanie A Ward; Kerrie M Sanders; Sundeep Khosla; Robert G Cumming; Julie A Pasco; Megan A Bohensky; Peter R Ebeling; Robyn L Woods; Jessica E Lockery; Rory Wolfe; Jason Talevski
Journal:  Inj Prev       Date:  2015-05-21       Impact factor: 2.399

2.  The risk of falls on initiation of antihypertensive drugs in the elderly.

Authors:  D A Butt; M Mamdani; P C Austin; K Tu; T Gomes; R H Glazier
Journal:  Osteoporos Int       Date:  2013-04-24       Impact factor: 4.507

3.  Low blood pressure levels for fall injuries in older adults: the Health, Aging and Body Composition Study.

Authors:  Naoko Sagawa; Zachary A Marcum; Robert M Boudreau; Joseph T Hanlon; Steven M Albert; Celia O'Hare; Suzanne Satterfield; Ann V Schwartz; Aaron I Vinik; Jane A Cauley; Tamara B Harris; Anne B Newman; Elsa S Strotmeyer
Journal:  Eur J Ageing       Date:  2018-01-19

4.  Long-Term Blood Pressure Variability and Risk of Cardiovascular Disease Events Among Community-Dwelling Elderly.

Authors:  Michael E Ernst; Enayet K Chowdhury; Lawrence J Beilin; Karen L Margolis; Mark R Nelson; Rory Wolfe; Andrew M Tonkin; Joanne Ryan; Robyn L Woods; John J McNeil; Christopher M Reid
Journal:  Hypertension       Date:  2020-11-02       Impact factor: 10.190

5.  The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Authors:  Ian M Kronish; Amy I Lynch; Suzanne Oparil; Jeff Whittle; Barry R Davis; Lara M Simpson; Marie Krousel-Wood; William C Cushman; Tara I Chang; Paul Muntner
Journal:  Hypertension       Date:  2016-05-23       Impact factor: 10.190

6.  Effect of dihydropyridine calcium channel blockers on blood pressure variability in the SPRINT trial: a treatment effects approach.

Authors:  Adam de Havenon; Nils Petersen; Zoe Wolcott; Eric Goldstein; Alen Delic; Nazanin Sheibani; Mohammad Anadani; Kevin N Sheth; Maarten Lansberg; Tanya Turan; Shyam Prabhakaran
Journal:  J Hypertens       Date:  2022-03-01       Impact factor: 4.844

7.  Association between gaps in antihypertensive medication adherence and injurious falls in older community-dwelling adults: a prospective cohort study.

Authors:  Paul Dillon; Susan M Smith; Paul John Gallagher; Gráinne Cousins
Journal:  BMJ Open       Date:  2019-03-04       Impact factor: 2.692

8.  Visit-to-visit blood pressure variability is common in primary care patients: Retrospective cohort study of 221,803 adults.

Authors:  Finlay A McAlister; Brendan Cord Lethebe; Alexander A Leung; Rajdeep S Padwal; Tyler Williamson
Journal:  PLoS One       Date:  2021-04-02       Impact factor: 3.240

9.  Single Agent Antihypertensive Therapy and Orthostatic Blood Pressure Behaviour in Older Adults Using Beat-to-Beat Measurements: The Irish Longitudinal Study on Ageing.

Authors:  Mark Canney; Matthew D L O'Connell; Catriona M Murphy; Neil O'Leary; Mark A Little; Conall M O'Seaghdha; Rose Anne Kenny
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

10.  The global burden of falls: global, regional and national estimates of morbidity and mortality from the Global Burden of Disease Study 2017.

Authors:  Spencer L James; Lydia R Lucchesi; Catherine Bisignano; Chris D Castle; Zachary V Dingels; Jack T Fox; Erin B Hamilton; Nathaniel J Henry; Kris J Krohn; Zichen Liu; Darrah McCracken; Molly R Nixon; Nicholas L S Roberts; Dillon O Sylte; Jose C Adsuar; Amit Arora; Andrew M Briggs; Daniel Collado-Mateo; Cyrus Cooper; Lalit Dandona; Rakhi Dandona; Christian Lycke Ellingsen; Seyed-Mohammad Fereshtehnejad; Tiffany K Gill; Juanita A Haagsma; Delia Hendrie; Mikk Jürisson; G Anil Kumar; Alan D Lopez; Tomasz Miazgowski; Ted R Miller; G K Mini; Erkin M Mirrakhimov; Efat Mohamadi; Pedro R Olivares; Fakher Rahim; Lidia Sanchez Riera; Santos Villafaina; Yuichiro Yano; Simon I Hay; Stephen S Lim; Ali H Mokdad; Mohsen Naghavi; Christopher J L Murray
Journal:  Inj Prev       Date:  2020-01-15       Impact factor: 2.399

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.